50 results on '"Toyooka, Shinichi"'
Search Results
2. Postoperative Complications in Living Donors for Lung Transplantation
3. Successful Living-donor Lobar Lung Transplantation With BK Virus-related Hemorrhagic Cystitis Throughout the Perioperative Period
4. SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
5. A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)
6. Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery
7. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015†
8. Postoperative pyoderma gangrenosum exacerbated by granulocyte-colony stimulating factor after lung cancer surgery
9. Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non–Small-Cell Lung Cancer: Study Protocol
10. Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
11. MDT lung cancer care: Input from the Surgical Oncologist
12. EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey
13. A New Human Lung Adenocarcinoma Cell Line Harboring the EML4-ALK Fusion Gene
14. Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
15. Wedge Resection of the Bronchial Corner at the Bifurcation of the Lobar Bronchi for a Low-Grade Bronchial Tumor
16. New treatment strategy for patients with EGFR-mutant lung cancer
17. Knockdown of the Epidermal Growth Factor Receptor Gene to Investigate Its Therapeutic Potential for the Treatment of Non–Small-Cell Lung Cancers
18. A Case of Delayed Massive Hemothorax Caused by the Rupture of a Pulmonary Artery Pseudoaneurysm after Radiofrequency Ablation of Lung Tumors
19. Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells
20. Percutaneous radiofrequency ablation of clinical stage I non–small cell lung cancer
21. Role of Computed Tomography Fluoroscopy-Guided Cutting Needle Biopsy of Lung Lesions After Transbronchial Examination Resulting in Negative Diagnosis
22. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers
23. CT Fluoroscopy-Guided Biopsy of 1,000 Pulmonary Lesions Performed With 20-Gauge Coaxial Cutting Needles: Diagnostic Yield and Risk Factors for Diagnostic Failure
24. Percutaneous computed tomography-guided lung biopsy and pleural dissemination: An assessment by intraoperative pleural lavage cytology
25. Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment
26. Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension
27. Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung
28. DNA Methylation in Lung Cancer
29. Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients
30. Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung
31. A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery
32. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma
33. Long-term follow-up of living-donor single lobe transplantation for idiopathic pulmonary arterial hypertension in a child
34. Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less
35. Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancer
36. Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer
37. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion
38. The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants
39. Feasibility of Percutaneous Radiofrequency Ablation for Intrathoracic Malignancies: A large single-center experience
40. The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer
41. Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation
42. Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer
43. Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan
44. Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung
45. ABERRANT METHYLATION OF RASSF1A IN SMALL-SIZED LUNG ADENOCARCINOMA AND ITS RELATIONSHIP TO CLINICOPATHOLOGICAL FEATURES
46. EGFR Mutation and Response of Lung Cancer to Gefitinib
47. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer
48. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
49. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection
50. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.